| Neurobiology of migraine PJ Goadsby, AR Charbit, AP Andreou, S Akerman, PR Holland Neuroscience 161 (2), 327-341, 2009 | 427 | 2009 |
| Mechanisms of migraine as a chronic evolutive condition AP Andreou, L Edvinsson The journal of headache and pain 20 (1), 117, 2019 | 213 | 2019 |
| A prospective real-world analysis of erenumab in refractory chronic migraine G Lambru, B Hill, M Murphy, I Tylova, AP Andreou The Journal of Headache and Pain 21, 1-10, 2020 | 144 | 2020 |
| Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine AP Andreou, PR Holland, S Akerman, O Summ, J Fredrick, PJ Goadsby Brain 139 (7), 2002-2014, 2016 | 129 | 2016 |
| Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping T Sprenger, CL Seifert, M Valet, AP Andreou, A Foerschler, C Zimmer, ... Brain 135 (8), 2536-2545, 2012 | 122 | 2012 |
| The fifth cranial nerve in headaches JCA Edvinsson, A Viganò, A Alekseeva, E Alieva, R Arruda, C De Luca, ... The journal of headache and pain 21, 1-17, 2020 | 120 | 2020 |
| Primary headaches during lifespan A Straube, A Andreou The journal of headache and pain 20, 1-14, 2019 | 115 | 2019 |
| Acid‐sensing ion channel 1: A novel therapeutic target for migraine with aura PR Holland, S Akerman, AP Andreou, N Karsan, JA Wemmie, ... Annals of neurology 72 (4), 559-563, 2012 | 113 | 2012 |
| Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus O Summ, AR Charbit, AP Andreou, PJ Goadsby Brain 133 (9), 2540-2548, 2010 | 109 | 2010 |
| Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics J Sousa‐Valente, AP Andreou, L Urban, I Nagy British Journal of Pharmacology 171 (10), 2508-2527, 2014 | 107 | 2014 |
| Evidence for orexinergic mechanisms in migraine J Hoffmann, W Supronsinchai, S Akerman, AP Andreou, CJ Winrow, ... Neurobiology of disease 74, 137-143, 2015 | 96 | 2015 |
| Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel I Nagy, D Friston, JS Valente, JVT Perez, AP Andreou Capsaicin as a Therapeutic Molecule, 39-76, 2014 | 92 | 2014 |
| Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway AP Andreou, PJ Goadsby Cephalalgia 31 (13), 1343-1358, 2011 | 88 | 2011 |
| Therapeutic potential of novel glutamate receptor antagonists in migraine AP Andreou, PJ Goadsby Expert opinion on investigational drugs 18 (6), 789-803, 2009 | 88 | 2009 |
| A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches O Summ, AP Andreou, S Akerman, PJ Goadsby The journal of headache and pain 11, 477-483, 2010 | 82 | 2010 |
| Animal models of headache: from bedside to bench and back to bedside AP Andreou, O Summ, AR Charbit, M Romero-Reyes, PJ Goadsby Expert review of neurotherapeutics 10 (3), 389-411, 2010 | 78 | 2010 |
| GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus AP Andreou, KG Shields, PJ Goadsby Neurobiology of disease 37 (2), 314-323, 2010 | 78 | 2010 |
| Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies YW Woldeamanuel, AP Andreou, RP Cowan Journal of the Neurological Sciences 342 (1-2), 1-15, 2014 | 67 | 2014 |
| Emerging drugs for migraine treatment: an update G Lambru, AP Andreou, M Guglielmetti, P Martelletti Expert opinion on emerging drugs 23 (4), 301-318, 2018 | 61 | 2018 |
| Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation AP Andreou, PR Holland, PJ Goadsby British journal of pharmacology 157 (3), 464-473, 2009 | 51 | 2009 |
